Bio-Reference Labs Signs Marketing Agreement With TD Waterhouse; Alliance to Provide a Full Array of Financial Services to Members of CareEvolve and Other BRLI Web Sites.

Business, High-Tech and Health Editors

ELMWOOD PARK, N.J.--(BUSINESS WIRE)--Aug. 22, 2000

Bio-Reference Laboratories, Inc (Nasdaq Small Cap-"BRLI"), announced an Agreement with TD Waterhouse, the global online financial services firm, to provide financial services to members of CareEvolve, BRLI's eHealthcare connectivity portal. Under the terms of the Agreement, CareEvolve will be afforded access to financial products and services through TD Waterhouse.

This arrangement also provides for TD Waterhouse to provide CareEvolve with advertising sponsorship. This arrangement for on-line financial services offers a special enhancement to CareEvolve's other office-based services, such as electronic payer enrollment, claims submission, remittance advice, eligibility verification, secure messaging, prescription services and lab reporting that CareEvolve is offering to physicians.

TD Waterhouse is a subsidiary of TD Waterhouse Group, Inc. which serves over 4.2 million customer accounts worldwide, with locations in the United States, Canada, the United Kingdom, Hong Kong, Australia, Japan and India. The company offers a flat-fee commission schedule of just $12 on market orders for stocks up to 5,000 shares, together with savings on bond and option transactions, compared to full-commission brokers.

Through the online system to be offered by CareEvolve, physicians will have full access to TD Waterhouse's banking services, on-line brokerage services and credit and debit card services, along with free investment information and research. In addition to its web-based access channel, TD Waterhouse maintains over 170 retail branches nationwide where customers can meet with representatives face to face to receive answers to account questions and help with investment decisions.

Marc Grodman, M.D., Chairman and CEO of BRLI, stated, "TD Waterhouse offers another area of service that physicians will want to use in order for CareEvolve to become their connectivity portal to the Internet. CareEvolve has already put together the key elements that will be needed to allow the physician to migrate into an enhanced eHealthcare marketplace with its secure messaging system allowing access to payers, vendors, patients and physicians, as well as lab reporting, appointment scheduling, prescription ordering and other e-services. TD Waterhouse enhances those office practice solutions and enables the physician to extend the portal beyond the direct office needs of his practice and into the complex area of full financial services." For additional information about BRLI, please visit www.bioreference.com, www.doctorny.com, www.drugscreenlab.com, www.drugabusekit.com, www.bioincubator.com, and www.rightbodyfoods.com.

BRLI, is a multi-faceted Health Services and Information Company as well as the largest regional clinical laboratory in the North East United States. It has major market positions in physician offices, nursing homes and correctional institutions. Its toxicology division performs employee drug testing for major corporations nationwide, as well as for drug treatment centers and psychiatric hospitals. CareEvolve.com, a wholly owned subsidiary of BRLI, is a Physician based health portal that seeks to enhance physician-patient and physician-payer electronic communications on a secured basis, including communicating laboratory results, e-mail, prescriptions, payer verification and eligibility, as well as offering other Internet based services to its physician members. These services will be provided through an Internet connectivity backbone.

The Company's common stock is traded on the Nasdaq Small Cap system under the symbol "BRLI."

Statements included in this release that are not historical in nature, are intended to be, and are hereby identified as "forward-looking statements". Statements looking forward in time are included in this Annual Report pursuant to the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Such statements involve known and unknown risks and uncertainties that may cause the Company's actual results in future periods to be materially different from any future performance suggested herein.

TD Waterhouse Group, Inc., (NYSE: TWE), also known as "TD Waterhouse," provides investors with a broad range of brokerage, mutual fund, banking and other consumer financial products on an integrated basis. In the United States, TD Waterhouse is the only online discount broker to have a retail branch in all 50 states. Worldwide, TD Waterhouse currently services 4.2 million customer accounts in the United States, Canada, the United Kingdom, Australia, Hong Kong, Japan and India. TD Waterhouse can be found on the Internet at www.tdwaterhouse.com and on America Online at Keyword: TD Waterhouse.

This release may contain forward-looking statements. Our statements, which reflect management's beliefs and expectations, are subject to risks and uncertainties that may cause actual results to differ materially from these statements. For a discussion of such risks and uncertainties, please refer to the documents we file from time to time with the Securities and Exchange Commission.